Terry P. Mamounas, MD, MPH, on Long-Term Implications of Extended Aromatase Inhibitor Therapy for Breast Cancer

Posted: Thursday, July 29, 2021

Terry P. Mamounas, MD, MPH, of the University of Florida Health Cancer Center, discusses the possible value of extended aromatase inhibitor treatment for women with hormone receptor–positive breast cancer, especially after 4 years for some subsets of patients.